CRP and acute coronary syndrome: A pilot randomized controlled trial assessing the effect of colchicine (1 mg per day) compared with placebo on high sensitivity C-reactive protein in patients with acute coronary syndrome or acute stroke revealed that it did not significantly reduce absolute hs-CRP at 30 days [median 1.0 mg/L (range 0.2, 162.0) versus 1.5 mg/L (0.2, 19.8), p = 0.22] [70].